SCHEMBL30552516

SCHEMBL30552516

N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 3/20 0.49
▸ NRP1 O14786 2/20 0.45
▸ NTSR2 O95665 2/20 0.43
▸ NTSR1 P30989 2/20 0.43
▸ OPRK1 P41145 7/20 0.43
▸ OPRM1 P35372 6/20 0.43
▸ DPP4 P27487 1/20 0.41
▸ FAP Q12884 1/20 0.41
▸ DPP8 Q6V1X1 1/20 0.41
▸ DPP9 Q86TI2 1/20 0.41
▸ DPP7 Q9UHL4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30422984 0.98 ACE (0.47) ACENRP1NTSR2NTSR1OPRK1
SCHEMBL30672574 0.96 ACE (0.46) ACENRP1NTSR2NTSR1OPRK1
SCHEMBL5507610 0.96 NRP1 (0.48) ACENRP1NTSR2NTSR1OPRK1
SCHEMBL5507620 0.96 NRP1 (0.48) ACENRP1NTSR2NTSR1OPRK1
SCHEMBL29802045 0.95 OPRK1 (0.49) ACENRP1NTSR2NTSR1OPRK1
SCHEMBL29721451 0.95 ACE (0.45) ACENRP1NTSR2NTSR1OPRK1
SCHEMBL30909415 0.94 ACE (0.44) ACENRP1OPRK1OPRM1
SCHEMBL29721101 0.93 ACE (0.45) ACENRP1NTSR2NTSR1OPRK1
SCHEMBL6362164 0.92 NRP1 (0.45) ACENRP1NTSR2NTSR1OPRK1
SCHEMBL31214578 0.91 ACE (0.45) ACEOPRK1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188139-A1 VEGF-C MUTEINS FOR SELECTIVE LYMPHATIC STIMULATION YALE UNIVERSITY (US) 2025-06-12 — — US disclosed
CN-119522235-A VEGF-C muteins for selective lymphatic stimulation 耶鲁大学 2025-02-25 — — CN disclosed
EP-4490175-A2 VEGF-C MUTEINS FOR SELECTIVE LYMPHATIC STIMULATION Yale University (US) 2025-01-15 — — EP disclosed
WO-2024168252-A2 USE OF INHIBITORS OF VEGF-C SIGNALING FOR INHIBITING IMMUNE RESPONSES AND INCREASING GENE THERAPY EFFICACY YALE UNIVERSITY (US) 2024-08-15 — — WO disclosed
WO-2023172964-A2 VEGF-C MUTEINS FOR SELECTIVE LYMPHATIC STIMULATION YALE UNIVERSITY (US) 2023-09-14 — — WO disclosed
Send feedback